CO2-Laser Treatment in Patients With Diabetic Infected Foot Ulcers
DULCIS
A Randomised, Open Label, Controlled Clinical Study to Evaluate the Efficacy and Safety of CO2-Laser Treatment in Patients With Diabetic Infected Foot Ulcers
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The study is aimed at comparing debridement either with CO2 laser or traditional surgery in patients with infected diabetic foot ulcers. The principal endpoint is bacterial load immediately after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 3, 2016
CompletedFirst Posted
Study publicly available on registry
February 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedResults Posted
Study results publicly available
December 6, 2016
CompletedDecember 6, 2016
October 1, 2016
2 months
February 3, 2016
August 19, 2016
October 13, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Bacterial Load
Percent change in bacterial colonies from baseline.
Percent change in bacterial colonies from baseline. Variation from baseline and immediately after the end of procedure.
Secondary Outcomes (4)
Pain: Scores of Brief Pain Inventory
During procedure.
Fibrin: Percent of Ulcer Area Covered by Fibrin
Baseline and immediately after the end of procedure
Granulation: Percent of Ulcer Area Covered by Granulation.
Baseline and immediately after procedure
Bleeding: Proportion of Patients With Bleeding Necessitating Haemostasis
during procedure
Study Arms (2)
CO2 laser
EXPERIMENTALUlcer debridement with laser-CO2 (DEKA SmartXide2 c80-El.En, Florence Italy)
Traditional surgery
ACTIVE COMPARATORUlcer debridement with traditional surgery
Interventions
Eligibility Criteria
You may qualify if:
- Diabetes
- Infected foot ulcer (with clinical signs of infection)
- Ulcer area between 0.5 and 150 cm2
- More than 50% of ulcer area covered by fibrin and/or necrosis
- Texas score \<3
You may not qualify if:
- Need for revascularization
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Matteo Monami, Director Diabetic Foot Unit
- Organization
- AOU Careggi
Study Officials
- PRINCIPAL INVESTIGATOR
Edoardo Mannucci, MD
University of Florence
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Diabetology
Study Record Dates
First Submitted
February 3, 2016
First Posted
February 9, 2016
Study Start
January 1, 2016
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
December 6, 2016
Results First Posted
December 6, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share